NOLASCO, SANTI
 Distribuzione geografica
Continente #
EU - Europa 85
NA - Nord America 65
AF - Africa 58
AS - Asia 22
Totale 230
Nazione #
US - Stati Uniti d'America 65
IT - Italia 56
CI - Costa d'Avorio 40
IE - Irlanda 25
SN - Senegal 18
CN - Cina 14
IN - India 5
FI - Finlandia 2
HK - Hong Kong 2
NL - Olanda 2
SG - Singapore 1
Totale 230
Città #
Abidjan 40
Dublin 25
Ashburn 18
Dakar 18
Milan 8
Catania 7
Biancavilla 6
Pune 5
Seattle 5
Boardman 4
Mascalucia 3
Naples 3
Abbiategrasso 2
Bitonto 2
Bologna 2
Corato 2
Laives 2
New York 2
Rome 2
Tai Wan 2
Amsterdam 1
Dordrecht 1
Genoa 1
Helsinki 1
Lappeenranta 1
Los Angeles 1
Messina 1
Monzuno 1
Trabia 1
Verona 1
Washington 1
Totale 169
Nome #
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children 37
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 21
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 17
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 17
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 17
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 16
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 15
Tezepelumab for asthma 14
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 13
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 13
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 11
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 11
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 11
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 10
Comparability of asthma control test scores between self and physician-administered test 10
Switching Biological Therapies in Severe Asthma 6
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 5
Personalized Medicine in Asthma: Current Approach and Future Perspectives 4
Are we overlooking the lung function in the definition of severe asthma remission? 2
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 2
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 1
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 1
Totale 254
Categoria #
all - tutte 1.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202389 0 0 0 0 0 0 25 29 20 4 2 9
2023/2024165 6 29 22 19 6 47 4 21 3 8 0 0
Totale 254